» Articles » PMID: 10216128

Determination of the Clonal Origin of Multiple Human Hepatocellular Carcinomas by Cloning and Polymerase Chain Reaction of the Integrated Hepatitis B Virus DNA

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1999 Apr 27
PMID 10216128
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The poor prognosis of hepatocellular carcinoma (HCC) is partly the result of the high rate of recurrence that is caused either by intrahepatic metastasis (IM) or independent multicentric occurrence (MO). For convenience, discrimination of IM and MO is based on pathological findings, but reliable parameters are not sufficiently established. In the case of hepatitis B virus (HBV)-associated HCC, molecular discrimination of IM from MO can be achieved by comparison of integrated HBV DNAs. However, Southern blotting cannot be used for this purpose when one tumor is saved in frozen form and the other is in paraffin-embedded form. To solve this problem, we employed polymerase chain reaction (PCR) assays to confirm the clonality of primary and recurrent tumors. From the frozen tissue, we determined the junction between the integrated HBV and flanking genomic DNA by molecular cloning, and checked the existence of an identical junction in the DNA of paraffin-embedded tissue by PCR. Using this method, as well as Southern blotting, we proved in 6 of 8 patients that two nodular HCC lesions resected metachronously or simultaneously were caused by MO, while the remaining 2 cases were caused by IM. In 1 IM case, band patterns between two HCCs detected by Southern blotting were not identical.

Citing Articles

Detection of γ-OHPdG in Circulating Tumor Cells of Patients With Hepatocellular Carcinoma as a Potential Prognostic Biomarker of Recurrence.

Aggarwal M, Kuo M, Zhu Z, Gould S, Zhang K, Johnson P Gastro Hep Adv. 2024; 3(6):809-820.

PMID: 39280920 PMC: 11401592. DOI: 10.1016/j.gastha.2024.04.006.


HBV-integrated local genomic alterations reveal multicentric independent occurrences of multifocal HCC.

Zou H, Wang Y, Lu L, Yao K, Wang C, Ma K Clin Transl Med. 2023; 13(6):e1313.

PMID: 37382888 PMC: 10309081. DOI: 10.1002/ctm2.1313.


Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.

Milana F, Polidoro M, Famularo S, Lleo A, Boldorini R, Donadon M Cancers (Basel). 2023; 15(2).

PMID: 36672457 PMC: 9856445. DOI: 10.3390/cancers15020508.


Spatial and temporal expansion of intrahepatic metastasis by molecularly-defined clonality in multiple liver cancers.

Yamamoto S, Midorikawa Y, Nagae G, Tatsuno K, Ueda H, Moriyama M Cancer Sci. 2019; 111(2):601-609.

PMID: 31845427 PMC: 7004543. DOI: 10.1111/cas.14282.


Three cases of hepatocellular carcinoma treated 4 times with proton beams.

Murakami M, Fukumitsu N, Okumura T, Numajiri H, Murofushi K, Ohnishi K Mol Clin Oncol. 2019; 12(1):31-35.

PMID: 31814974 PMC: 6888171. DOI: 10.3892/mco.2019.1950.